By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Orexo AB 

Box 303

Uppsala    SE-751 05  Sweden
Phone: 46-0-18-780-88-00 Fax: 46-0-18-780-88-88



Company News
Orexo (ORXOF): Interim Report January-September 2016 10/20/2016 11:12:54 AM
Orexo (ORXOF): FDA Approves Unique Low Dosage Of Zubsolv 10/6/2016 11:53:33 AM
U.S. FDA Approves Orexo (ORXOF)'s Low Dose ZUBSOLV Buprenorphine And Naloxone Sublingual Tablets (CIII) 10/6/2016 7:28:14 AM
Mundipharma AG And Orexo (ORXOF) Announce EU Regulatory Submission For Zubsolv 10/4/2016 12:36:01 PM
Orexo (ORXOF) Appoints Nomination Committee And Publishes Financial Calendar 2016/2017 9/30/2016 4:06:33 PM
Orexo (ORXOF): Issue And Repurchase Of Class C Shares 9/22/2016 10:54:48 AM
Orexo (ORXOF) Completes 1,080 Patient REZOLV Study And Reports On Improved Treatment Of Opioid Dependent Patients 9/2/2016 9:36:47 AM
Orexo (ORXOF): Interim Report January-June 2016 7/12/2016 10:48:45 AM
Orexo (ORXOF) Welcomes Changes From U.S. Health And Human Services (HHS) Announcement Increasing Treatment Access For Opioid-Dependent Patients 7/8/2016 8:38:57 AM
Orexo (ORXOF) Welcomes Increased Access To Treatment For Patients With Opioid Dependence In The U.S. 7/7/2016 10:02:54 AM